Abacus Life (NASDAQ:ABL) Coverage Initiated by Analysts at Maxim Group
Maxim Group assumed coverage on shares of Abacus Life (NASDAQ:ABL – Free Report) in a research note issued to investors on Tuesday morning, MarketBeat reports. The brokerage issued a buy rating and a $14.00 price objective on the stock. A number of other equities research analysts also recently commented on ABL. B. Riley cut their […]
